FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022679652> ?p ?o ?g. }

• W2022679652 endingPage "1278" @default.
• W2022679652 startingPage "1274" @default.
• W2022679652 abstract "A significant weight gain and increase in serum leptin levels in the course of antiepileptic treatment with valproic acid (VPA) has been described in several clinical studies. With respect to the long treatment period in antiepileptic therapy, these side effects might increase insulin resistance and metabolic risk factors. We have studied clinical and laboratory effects of VPA treatment in a cohort of female patients (n = 22) and in patients treated with carbamazepine (CBZ) or lamotrigine monotherapy (n = 21). All study participants underwent an oral glucose tolerance test (OGTT) with 75 g glucose. Body mass index (BMI) in the VPA group was higher (28.1 [plusmn] 3.6 kg/m2) than in the control group (23.9 [plusmn] 3.7 kg/m2) (P [lt ] .039). While plasma glucose, serum leptin, insulin, and C-peptide levels did not differ significantly between the study groups in the fasting state, postprandial (pp) insulin and proinsulin levels were found to be significantly higher in the VPA than in the control group. In the course of the OGTT, serum insulin levels reached their peak values 1 hour postprandially with 68.8 [plusmn] 10.0 [mu ]U/mL in the VPA group and 49.8 [plusmn] 11.2 [mu ]U/mL in the control group (P [lt ] .042). After 2 hours, the corresponding serum insulin levels were 48.5 [plusmn] 25.2 [mu ]U/mL and 34.1 [plusmn] 17.2 [mu ]U/mL (P [lt ] .048) and the proinsulin levels 52.5 [plusmn] 30.2 pmol/L and 29.5 [plusmn] 12.0 pmol/L (P [lt ] .017). While BMI values in the non-VPA group showed a significant correlation only with the fasting values of insulin, proinsulin, and C-peptide, the BMI values of the VPA-treated group were also positively related to the 2-hour pp levels of insulin (R = .690; P [lt ] .001), proinsulin (R = .667; P [lt ] .001) and C-peptide (R = .502; P [lt ] .017). VPA is a fatty acid derivative, competes with free fatty acids (FFA) for albumin binding, and acts as a gamma aminobutyric acid (GABA)-ergic agonist, mechanisms, which are known to be involved in pancreatic [beta ]-cell regulation and insulin secretion. Therefore, it might be suspected that VPA therapy is associated with increased glucose stimulated pancreatic secretion and thus a higher body weight in the VPA group." @default.
• W2022679652 created "2016-06-24" @default.
• W2022679652 creator A5000905015 @default.
• W2022679652 creator A5011836854 @default.
• W2022679652 creator A5012161970 @default.
• W2022679652 creator A5059322984 @default.
• W2022679652 creator A5060239470 @default.
• W2022679652 creator A5076045134 @default.
• W2022679652 creator A5084045857 @default.
• W2022679652 date "2002-10-01" @default.
• W2022679652 modified "2023-09-27" @default.
• W2022679652 title "Increase in postprandial serum insulin levels in epileptic patients with valproic acid therapy" @default.
• W2022679652 cites W1865343003 @default.
• W2022679652 cites W1891714429 @default.
• W2022679652 cites W1964363319 @default.
• W2022679652 cites W1969572206 @default.
• W2022679652 cites W1974489840 @default.
• W2022679652 cites W1985372163 @default.
• W2022679652 cites W1988870963 @default.
• W2022679652 cites W1996713062 @default.
• W2022679652 cites W2010165204 @default.
• W2022679652 cites W2012116123 @default.
• W2022679652 cites W2020282477 @default.
• W2022679652 cites W2022933598 @default.
• W2022679652 cites W2028843279 @default.
• W2022679652 cites W2029078015 @default.
• W2022679652 cites W2035481611 @default.
• W2022679652 cites W2038686627 @default.
• W2022679652 cites W2047665976 @default.
• W2022679652 cites W2051163013 @default.
• W2022679652 cites W2061442310 @default.
• W2022679652 cites W2064017079 @default.
• W2022679652 cites W2065399143 @default.
• W2022679652 cites W2066736958 @default.
• W2022679652 cites W2068491028 @default.
• W2022679652 cites W2096773810 @default.
• W2022679652 cites W2105748867 @default.
• W2022679652 cites W2106270379 @default.
• W2022679652 cites W2116404316 @default.
• W2022679652 cites W2120557435 @default.
• W2022679652 cites W2125510262 @default.
• W2022679652 cites W2129316761 @default.
• W2022679652 cites W2129918346 @default.
• W2022679652 cites W2133485499 @default.
• W2022679652 cites W2138955442 @default.
• W2022679652 cites W2139454197 @default.
• W2022679652 cites W2140131270 @default.
• W2022679652 cites W2142602157 @default.
• W2022679652 cites W2146740930 @default.
• W2022679652 cites W2160234571 @default.
• W2022679652 cites W2170407184 @default.
• W2022679652 cites W2175474731 @default.
• W2022679652 cites W2330942385 @default.
• W2022679652 cites W2334337188 @default.
• W2022679652 cites W2430143578 @default.
• W2022679652 doi "https://doi.org/10.1053/meta.2002.34708" @default.
• W2022679652 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12370846" @default.
• W2022679652 hasPublicationYear "2002" @default.
• W2022679652 type Work @default.
• W2022679652 sameAs 2022679652 @default.
• W2022679652 citedByCount "61" @default.
• W2022679652 countsByYear W20226796522012 @default.
• W2022679652 countsByYear W20226796522013 @default.
• W2022679652 countsByYear W20226796522014 @default.
• W2022679652 countsByYear W20226796522015 @default.
• W2022679652 countsByYear W20226796522016 @default.
• W2022679652 countsByYear W20226796522017 @default.
• W2022679652 countsByYear W20226796522019 @default.
• W2022679652 countsByYear W20226796522022 @default.
• W2022679652 crossrefType "journal-article" @default.
• W2022679652 hasAuthorship W2022679652A5000905015 @default.
• W2022679652 hasAuthorship W2022679652A5011836854 @default.
• W2022679652 hasAuthorship W2022679652A5012161970 @default.
• W2022679652 hasAuthorship W2022679652A5059322984 @default.
• W2022679652 hasAuthorship W2022679652A5060239470 @default.
• W2022679652 hasAuthorship W2022679652A5076045134 @default.
• W2022679652 hasAuthorship W2022679652A5084045857 @default.
• W2022679652 hasConcept C118552586 @default.
• W2022679652 hasConcept C126322002 @default.
• W2022679652 hasConcept C134018914 @default.
• W2022679652 hasConcept C2777172819 @default.
• W2022679652 hasConcept C2777391703 @default.
• W2022679652 hasConcept C2778186239 @default.
• W2022679652 hasConcept C2778199505 @default.
• W2022679652 hasConcept C2779306644 @default.
• W2022679652 hasConcept C2780221984 @default.
• W2022679652 hasConcept C2780613262 @default.
• W2022679652 hasConcept C511355011 @default.
• W2022679652 hasConcept C71924100 @default.
• W2022679652 hasConcept C90061646 @default.
• W2022679652 hasConceptScore W2022679652C118552586 @default.
• W2022679652 hasConceptScore W2022679652C126322002 @default.
• W2022679652 hasConceptScore W2022679652C134018914 @default.
• W2022679652 hasConceptScore W2022679652C2777172819 @default.
• W2022679652 hasConceptScore W2022679652C2777391703 @default.
• W2022679652 hasConceptScore W2022679652C2778186239 @default.
• W2022679652 hasConceptScore W2022679652C2778199505 @default.
• W2022679652 hasConceptScore W2022679652C2779306644 @default.

• next